Clinical Pharmacokinetics of Vasodilators: Part II

By Kirsten R.  

Clinical Pharmacokinetics, Vol. 35, Iss. 1, 1998-07 ,pp. : 9-36

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I)

By Asami Akitoshi  

Journal of Natural Medicines, Vol. 64, Iss. 3, 2010-07 ,pp. : 281-287

Springer Publishing Company

Access to resources Recommend Favorite

Asenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolism

By Citrome Leslie  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 893-903

Informa Healthcare

Access to resources Recommend Favorite

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

By Staatz Christine E.   Goodman Lucy K.   Tett Susan E.  

Clinical Pharmacokinetics, Vol. 49, Iss. 3, 2010-03 ,pp. : 141-175

Adis International

Access to resources Recommend Favorite

Clinical pharmacokinetics of phenobarbital in neonates

By Touw D.J.   Graafland O.   Cranendonk A.   Vermeulen R.J.   van Weissenbruch M.M.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 2, 2000-12 ,pp. : 111-116

Elsevier

Access to resources Recommend Favorite